The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - BioDelivery Sciences (BDSI) on Monday entered into a $20 million senior secured loan with MidCap Financial and issued to the group a warrant to purchase … Continue Reading
Read nowMost Popular - Medivation (MDVN) has made a rapid come-back since investors exited en masse in mid-June as the company’s closest development-stage competitor was bought by J&J (JNJ). … Continue Reading
Read nowLong Ideas - On Monday after the close, Achillion Pharmaceuticals (ACHN) revealed that the FDA has placed a partial clinical hold on the development of lead candidate sovaprevir … Continue Reading
Read nowLong Ideas - We last covered Synageva BioPharma (GEVA) in early January, arguing that the company faced fundamental risks that made its valuation a concern moving forward. But … Continue Reading
Read nowRecap - Split-adjusted, Ohr Pharma (OHRP) is up 61% since PropThink covered the small-cap drug developer in mid-March. Some investors remain skeptical of the company’s lead asset, … Continue Reading
Read nowMost Popular - Shares of TG Therapeutics (TGTX) had a rough end to last week and a worse beginning to this week. But it was that weakness that … Continue Reading
Read nowLong Ideas - The Centers for Medicare and Medicaid Services (CMS) publicized a regulatory proposal on Thursday that cuts reimbursement payments for in-home health service providers by 3.5% … Continue Reading
Read now
